Hello Gretchen!
There are two things in your question that makes me concerned about pursuing a non-significant change.
Firstly, the shift from a plain MDDS to a product including SaMD features. To me, this sounds like you leave the easy, relaxed path for MDDS(1) and enter a more regulated world.
Secondly, just mentioning AI... If it is introduced or used by the SaMD features, I find it unlikely that the FDA would consider such change non-significant. But perhaps AI is already present in the MDDS and not utilized by the SaMD features? Then it would be a more straightforward discussion! ;)
(1)
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/medical-device-data-systems-medical-image-storage-devices-and-medical-image-communications-devices------------------------------
Christian Kaestner
Sweden
------------------------------
Original Message:
Sent: 07-Jan-2022 09:44
From: Gretchen Upton
Subject: Notice of Change SaMD accessory
Hello,
Has anyone had luck submitting a non-significant notice of change to an MDDS introducing a SaMD enabled accessory? The MDDS is also SW with AI-enabled, this change will take the device from MDDS to a Class A monitoring device. The client wants to try to pursue it as a non-significant change.
------------------------------
Gretchen Upton
RAC, CQA, CCRP
QA/RA consultant
San Antonio, TX
------------------------------